Ireland
--:--IST
Latest
Clinical Trials in France / NCT05175300
Recruiting Not applicable

Interest of a Highly Cross-linked Polyethylene Acetabular Component Doped With Vitamin E in Total Hip Arthroplasty of the Young and Active Subject

NCT05175300 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2023-03-24
Last updated
2025-12-03

Condition(s) studied

Hip Arthropathy

Investigational drug(s) / intervention(s)

Prosthesis with CoPXE couple.Prosthesis with CoC torque.

Prosthesis with CoPXE couple.: Prosthesis with a second-generation ceramic-on-highly cross-linked polyethylene (CoPXE) couple.

Prosthesis with CoC torque.: Prosthesis with ceramic-on-ceramic (CoC) torque.

Study summary

Interest of a highly cross-linked polyethylene acetabular component doped with vitamin E in total hip arthroplasty of the young and active subject.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Patient aged 18 to 65 years, * Who have signed their consent to participate in the study, * For whom an indication for total hip arthroplasty has been given Exclusion Criteria: * History of hip surgery * Indication for a dual mobility prosthesis (obese patient, dynamic spino-pelvic anomaly) * Hip dysplasia * Inflammatory rheumatic disease or any other progressive concomitant condition that may impact the patient's vital or functional prognosis * Sequelae of neurological disease or stroke * Pregnant or breastfeeding women * Mental deficiency or any other reason that may hinder the understanding or the strict application of the protocol * Patient likely not to return for follow-up visits * Patient already included in another therapeutic study protocol * Patient under court protection, guardianship or curatorship.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hôpital Privé Jean Mermoz Lyon France Recruiting

More GCS Ramsay Santé pour l'Enseignement et la Recherche trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05175300 on ClinicalTrials.gov ↗ ← All trials in France